Archives by Month:
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Five S&P 500-Beating Stocks To Buy For The Rest Of 2016
Worries over the global economic outlook, along with volatile oil prices and commodities rout, have led investors to dump riskier stocks and scurry toward safe-haven assets, such as gold and government bonds. While the U.S. economy with its moderate growth expectations amid the global mayhem offers an attractive investment opportunity, the global concerns have spread […]
2007 All Over Again, Part 4: “We Are Outsourcing Our Monetary Policy”
<< Read More: 2007 All Over Again? Let Us Count The Ways (And Remember What Happened Then) – Part 1 << Read More: 2007 All Over Again? Mega-Merger Edition – Part 2 <<Read more: 2007 All Over Again: Banks Starting To Implode – Part 3 In that deservedly-famous 2006 CNBC debate between Peter Schiff and economist Arthur Laffer (in […]
What This Week’s Federal Reserve Interest Rate News Means For Markets In 2016
Global stocks and commodities are rallying today (Wednesday) following the U.S.Federal Reserve interest rate announcement from Chair Janet Yellen yesterday. Yellen was extremely dovish in yesterday’s Federal Reserve interest rate statement, saying the central bank needs to remain cautious when hiking rates this year. The Fed has also cut the number of rate hikes it plans to hold […]
Crude Crashes Into Red Post-Yellen
Well, that escalated quickly… Gold is clinging to unch, bonds are down, and now crude has crashed back into the red post-Yellen… Only stocks remain positive – which makes perfect sense given Yellen’s implied downgrade of every positive economic indicator (and the 22.5x GAAP P/E).
Can Big Money Limit The Upside Potential For Facebook Stock?
123RF On the 4th of March, Eric Chemi announced on CNBC that Facebook (NASDAQ:FB) is now among the top 20 most widely held stocks. This is the first time that Facebook has made it on the top 20 list of the most held stocks among institutional equity investors. Facebook surged from a ranking of 23rd in September […]
Pfizer, Allergan Receive Request For Additional Information From FTC
Pfizer (PFE) and Allergan (AGN) announced that the companies have received a request for additional information from the U.S. Federal Trade Commission with respect to their previously announced pending combination. The request for information from the FTC, often referred to as a “second request,” was fully anticipated as part of the regulatory process under the […]
To Money Or Not Money, That Is The Question
When former Dallas Fed President Richard Fisher stepped down last March after a decade in that role, the New York Times (of course) wrote his professional obituary under the headline Richard Fisher, Often Wrong But Seldom Boring. Fisher had apparently viewed his own philosophical root and career at the Fed as something of an updated Paul […]
Tuning In To Trust & Ethics: Leadership At Barclays Bank
Organizations and their leaders often find themselves caught in “trust and ethics traps.” Jes Staley the newly appointed American CEO of the beleaguered British Barclays Bank is one such leader. In fact, as he recently announced in this BBC News Article “I do believe that trust is returning to our institution. But we will never rest, we […]
Apple V. FBI And Apple’s New Products On Fox 5
(Video length 00:03:58) Shelly Palmer talks about the Apple v. FBI case and things you need to know about the Apple Watch and Apple’s new iPhone SE and new iPad on Fox 5 with Ben Simmoneau and Juliet Huddy. Original Airdate: March 29, 2016
Acadia Pharmaceuticals: Nuplazid Gets Overwhelming Backing
Acadia Pharmaceuticals (ACAD 25.86 +2.06 8.63%) made it. The company’s New Drug Application (NDA) for Nuplazid was overwhelmingly backed by the advisory panel for approval. 12 members in the panel voted in favor of an approval while just 2 voted against it. Trading in ACAD shares was halted on Tuesday as the Ad Comm met to review the NDA. But […]
